Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer

This study aims to explore the role of Traditional Chinese Medicine (TCM) based on syndrome differentiation in reducing chemotherapy side effects, lowering the risk of metastasis and recurrence, and improving survival rates in postoperative colorectal cancer patients through a prospective, single-arm interventional clinical trial.

NCT Number	NCT06596343
Lead Sponsor	Sir Run Run Shaw Hospital
Conditions	Locally Advanced Colorectal Cancer, Postoperative Adjuvant Therapy
Enrollment	80 participants
Start Date	2024-10
Primary Completion	2027-09-30 (estimated)
Study Completion	2027-09-30 (estimated)
Updated on ClinicalTrials.gov	2024-09-19